DNA synthesis inhibitors: Metronidazole

14,134views

00:00 / 00:00

Videos

Notes

DNA synthesis inhibitors: Metronidazole

Pharmacology

Antibiotics

Protein synthesis inhibitors: Aminoglycosides

Antimetabolites: Sulfonamides and trimethoprim

Antituberculosis medications

Miscellaneous cell wall synthesis inhibitors

Protein synthesis inhibitors: Tetracyclines

Cell wall synthesis inhibitors: Penicillins

Miscellaneous protein synthesis inhibitors

Cell wall synthesis inhibitors: Cephalosporins

DNA synthesis inhibitors: Metronidazole

DNA synthesis inhibitors: Fluoroquinolones

Mechanisms of antibiotic resistance

Antivirals

Integrase and entry inhibitors

Nucleoside reverse transcriptase inhibitors (NRTIs)

Protease inhibitors

Hepatitis medications

Non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Neuraminidase inhibitors

Herpesvirus medications

Antifungals

Azoles

Echinocandins

Miscellaneous antifungal medications

Antiparasitics

Anthelmintic medications

Antimalarials

Anti-mite and louse medications

Assessments

DNA synthesis inhibitors: Metronidazole

Flashcards

0 / 5 complete

Flashcards

DNA synthesis inhibitors: Metronidazole

of complete

Memory Anchors and Partner Content

External References

First Aid

2022

2021

2020

2019

2018

2017

2016

Anaerobic organisms

metronidazole p. 192

Bacteroides spp.

metronidazole p. 192

Clindamycin

metronidazole vs p. 189

Clostridium difficile p. , 136

metronidazole p. 192

Entamoeba histolytica

metronidazole p. 192

Helicobacter pylori p. , 144

metronidazole p. 192

Hypotension

metronidazole p. 192

Metronidazole p. 192

bacterial vaginosis p. 146

clindamycin vs p. 189

Clostridium difficile p. , 136

for Crohn disease p. 391

disulfiram-like reaction p. 252

Giardia lamblia p. , 152

Helicobacter pylori p. , 144

mechanism (diagram) p. 184

Trichomonas vaginalis p. , 725

vaginal infections p. 179

vaginitis p. 155

Tachycardia

metronidazole p. 192

Transcript

Contributors

Kaia Chessen, MScBMC

Alex Aranda

Tanner Marshall, MS

DNA synthesis inhibitors are a group of antibiotics that target the synthesis of DNA in bacteria and other organisms. Metronidazole, a 5-nitroimidazole, prevents the synthesis of nucleic acids, which are the building blocks of DNA, and is effective against many bacteria and protozoans. Metronidazole and related 5-nitroimidazoles are relatively nontoxic to humans. This is because in order to function, they need to be reduced by a protein called ferredoxin, which contains sulfur and iron. This protein is commonly found in anaerobic bacteria and protozoans, but not in humans and aerobic bacteria. Now, this protein can donate an electron to metronidazole, causing it to form free radicals which will damage the DNA, causing it to fragment. Without the DNA as a template, the organism can’t synthesize any more nucleic acids like DNA or mRNA, which will lead to cell death.

Metronidazole can be taken perorally, but it’s also available in an IV form and as topical creams. It penetrates well into body tissues and fluids, including vaginal secretions, seminal fluid, saliva, breast milk, and cerebrospinal fluid, but does not cross over the placenta. This medication can treat many anaerobic bacterial infections like Clostridium difficile, which can cause pseudomembranous enterocolitis in people taking other antibiotics. Another common organism treated by this medication is Helicobacter pylori, a common bacteria that causes gastritis and peptic ulcers. However, it should be used in combination with other antimicrobials and proton pump inhibitors as part of a triple therapy for the best outcome. Next, Lactobacillus species and other anaerobes that can cause bacterial vaginosis are all treated by metronidazole. For protozoan infections, it’s the medication of choice for amoebiasis, an infection of the gut caused by Entamoeba histolytica. It’s the medication of choice against Trichomonas vaginalis as well, which also causes vaginosis. Finally, metronidazole is highly effective against giardiasis, or beaver fever, which is an infection of the gut by Giardia lamblia.

Elsevier

Copyright © 2023 Elsevier, except certain content provided by third parties

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX